OM
AYLA

Opaleye Management’s Ayala Pharmaceuticals, Inc. Common Stock AYLA Stock Holding History

Opaleye Management’s Portfolio AYLA Stock Details AYLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-108,551
Closed -$1.18M – 62
2021
Q1 		$1.18M Buy
+108,551
New +$1.55M 0.17% 53

Other funds holding AYLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $38.8B AUM 41.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Opaleye Management's AYLA Position: Q2 2021 in Review

Opaleye Management sold out of Ayala Pharmaceuticals, Inc. Common Stock (AYLA) in Q2 2021, closing a stake of 108,551 shares — an estimated $1.18M sold.

Opaleye Management first reported a position in AYLA in Q1 2021 and held it in 1 quarter. The position peaked at $1.18M in Q1 2021. 12 funds tracked by Wall St. Rank hold AYLA as of Q2 2021.

  • Opaleye Management reported no remaining Ayala Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Opaleye Management sold 108,551 Ayala Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $1.18M.
  • Opaleye Management first reported a position in Ayala Pharmaceuticals, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Opaleye Management's Ayala Pharmaceuticals, Inc. Common Stock position peaked at $1.18M in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Ayala Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Opaleye Management's 13F filing for Q2 2021, filed 16 Aug 2021.